- Additional information
|Product Name:||Terlipressin Acetate|
|Synonyms:||[N-α-Triglycyl-8-lysine]-vasopressin;130: PN: WO2010033207 SEQID: 171 claiMed protein;1-Triglycyl-8-lysine Vasopressin;Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin;Nα-Glycyl-glycyl-glycyl-lysine-vasopressin;Nα-Glycylglycylglycyl-vasopressin;Nα-Gly-Gly-Gly-8-Lys-vasopressin;Terlipressin, Terlipressine, Terlipressina, Terlipressinum|
|Boiling point:||1824.0±65.0 °C(Predicted)|
|Storage:||Keep in dark place,Inert atmosphere,Store in freezer, under -20°C|
|Solubility:||Soluble in DMSO, not in water|
|Shipping Condition:||Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.|
Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help. Indications for use include norepinephrine-resistant septic shock and hepatorenal syndrome. In addition, it is used to treat bleeding esophageal varices. Terlipressin is currently not available in the United States, or Canada, but it is available in New Zealand, Australia, much of Europe, India & UAE.
Terlipressin acetate is a vasopressin analog with potent vasoactive properties and a highly selective vasopressin V1 receptor agonist, which can reduce visceral blood flow and portal pressure and control acute varicose rupture bleeding. Terlipressin acetate has anti-inflammatory and antioxidant effects, and can be used in the study of hepatorenal syndrome and norepinephrine-resistant septic shock.